Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design.

Wiegand RE, Chickery S, Yang DH, Ball SW, DeSilva MB, Dascomb K, Irving SA, Natarajan K, Klein NP, Grannis SJ, Ong TC, Rowley EAK, Yates A, Zhuang Y, Wilson S, McEvoy CE, Essien IJ, Akinsete OO, Naleway AL, Koppolu P, Zerbo O, Hansen JR, Jacobson KB, Block L, Dixon BE, Duszynski T, Rogerson C, Barron MA, Chavez C, Mak J, Ciesla AA, Godfrey M, Kautz A, Najdowski M, Link-Gelles R, DeCuir J, Payne AB

Open source

DOI
10.1001/jamanetworkopen.2026.25152
Published
2026 Jun 1
Container
JAMA network open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamanetworkopen.2026.25152,
  title = {Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design.},
  author = {Wiegand RE and Chickery S and Yang DH and Ball SW and DeSilva MB and Dascomb K and Irving SA and Natarajan K and Klein NP and Grannis SJ and Ong TC and Rowley EAK and Yates A and Zhuang Y and Wilson S and McEvoy CE and Essien IJ and Akinsete OO and Naleway AL and Koppolu P and Zerbo O and Hansen JR and Jacobson KB and Block L and Dixon BE and Duszynski T and Rogerson C and Barron MA and Chavez C and Mak J and Ciesla AA and Godfrey M and Kautz A and Najdowski M and Link-Gelles R and DeCuir J and Payne AB},
  year = {2026},
  journal = {JAMA network open},
  doi = {10.1001/jamanetworkopen.2026.25152},
  url = {https://doi.org/10.1001/jamanetworkopen.2026.25152}
}

RIS

TY  - JOUR
TI  - Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design.
AU  - Wiegand RE
AU  - Chickery S
AU  - Yang DH
AU  - Ball SW
AU  - DeSilva MB
AU  - Dascomb K
AU  - Irving SA
AU  - Natarajan K
AU  - Klein NP
AU  - Grannis SJ
AU  - Ong TC
AU  - Rowley EAK
AU  - Yates A
AU  - Zhuang Y
AU  - Wilson S
AU  - McEvoy CE
AU  - Essien IJ
AU  - Akinsete OO
AU  - Naleway AL
AU  - Koppolu P
AU  - Zerbo O
AU  - Hansen JR
AU  - Jacobson KB
AU  - Block L
AU  - Dixon BE
AU  - Duszynski T
AU  - Rogerson C
AU  - Barron MA
AU  - Chavez C
AU  - Mak J
AU  - Ciesla AA
AU  - Godfrey M
AU  - Kautz A
AU  - Najdowski M
AU  - Link-Gelles R
AU  - DeCuir J
AU  - Payne AB
PY  - 2026
JO  - JAMA network open
DO  - 10.1001/jamanetworkopen.2026.25152
UR  - https://doi.org/10.1001/jamanetworkopen.2026.25152
ER  - 

APA

RE, W., S, C., DH, Y., SW, B., MB, D., K, D., SA, I., K, N., NP, K., SJ, G., TC, O., EAK, R., A, Y., Y, Z., S, W., CE, M., IJ, E., OO, A., AL, N., P, K., O, Z., JR, H., KB, J., L, B., BE, D., T, D., C, R., MA, B., C, C., J, M., AA, C., M, G., A, K., M, N., R, L., J, D., & AB, P. (2026). Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design.. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2026.25152

Source records